New Case Study Describes California Neonatal Units Role in babyLance Heelstick Device Development
Summary
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site Press Releases MediPurpose Press Release Receive press releases from MediPurpose: By Email RSS Feeds: New Case Study Describes California Neonatal Units Role in babyLance Heelstick Device Development Results from Simulated and Clinical Use Survey at Citrus Valley Medical Center Atlanta, GA, February 02, 2013 --( The case study describes how Citrus Valley Medical Centers Family Birth & Newborn Center in West Covina, California collaborated with MediPurpose throughout its babyLance heelstick device design process to: * Provide highly qualified "voice of the customer" (VOC) input about the original and the new babyLance * Shape and validate end-user preferences, expectations and requirements for the ideal heelstick solution * Evaluate new babyLance prototypes and pre-production models at key stages of the redesign process * Participate in simulated and clinical use validation studies of the redesigned babyLance Two previously published white papers summarized the results of the simulated and clinical use studies conducted at multiple facilities in the United States and Europe."We owe Citrus Valley Medical Center a tremendous amount of gratitude," said MediPurpose founder and CEO Patrick Yi, who also led the babyLance design team.Combined with a redesigned trigger mechanism, the heelstick device is easy to activate, helping to deliver a consistent incision without damaging the babys tender nerve fibers.Atlanta, GA, February 02, 2013 --( PR.com )-- MediPurpose(tm), a master distributor and manufacturer of medical devices, today announced the publication of a new case study, “Reinventing a Better babyLance(tm) Infant Heel Incision Device: Collaboration with Citrus Valley Medical Center.”The case study describes how Citrus Valley Medical Centers Family Birth & Newborn Center in West Covina, California collaborated with MediPurpose throughout its babyLance heelstick device design process to:* Provide highly qualified "voice of the customer" (VOC) input about the original and the new babyLance* Shape and validate end-user preferences, expectations and requirements for the ideal heelstick solution* Evaluate new babyLance prototypes and pre-production models at key stages of the redesign process* Participate in simulated and clinical use validation studies of the redesigned babyLanceTwo previously published white papers summarized the results of the simulated and clinical use studies conducted at multiple facilities in the United States and Europe."We owe Citrus Valley Medical Center a tremendous amount of gratitude," said MediPurpose founder and CEO Patrick Yi, who also led the babyLance design team.